NeoGenomics, Inc. (NEO): Stock Offering News

NEO – Priced underwritten public offering of 9.8M common stock at $12.75/share.


Key Facts Surrounding This News Item


  • NEO had a POWR Rating of B (Buy) coming into today.
  • NEO was -6.11% below its 10-Day Moving Average coming into today.
  • NEO was -6.20% below its 20-Day Moving Average coming into today.
  • NEO was -3.51% below its 50-Day Moving Average coming into today.
  • NEO was 12.65% above its 100-Day Moving Average coming into today.
  • NEO was 30.26% above its 200-Day Moving Average coming into today.
  • NEO had returned +47.52% year-to-date leading up to today’s news, versus a +7.73% return from the benchmark S&P 500 during the same period.

More Info About NeoGenomics, Inc. (NEO)


NeoGenomics, Inc. operates a network of cancer-focused testing laboratories providing genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, and other laboratories in the United States. The company was founded in 2001 and is based in Fort Myers, Florida. View our full NEO ticker page with ratings, news, and more.

Try StockNews.com Premium Today!


Get access to our daily newsletters, Best Stocks List, POWR Ratings, and much more!
Free for 14 days -- no credit card required!

Sign Up Now

NEO at a Glance

NEO Current POWR Rating™
Overall POWR Rating™
NEO Current Price $12.84 1.34%
More NEO Ratings, Data, and News

NEO Price Reaction

The day of this event (Aug. 10, 2018)
NEO Closing Price$12.50 4.36%
NEO Volume6,176,200
1,418.67% from avg
Leading up to this event
NEO 1-mo return8.28%
After this event
NEO 1-day return2.83%
NEO 3-day return4.31%
NEO 5-day return3.16%

NEO Price Chart



More NeoGenomics, Inc. (NEO) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All NEO News
Page generated in 0.8987 seconds.